Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00471250 · ClinicalTrials.gov registry record

Collection of Lung Fluid and Tissue Samples for Research

A clinical trial of Respiratory Tract Diseases and Bronchoscopy, sponsored by National Heart, Lung, and Blood Institute (NHLBI).

Recruiting
Registry status
550
Enrollment target
1
Study location

NCT00471250: Recruiting study of Respiratory Tract Diseases and Bronchoscopy, sponsored by National Heart, Lung, and Blood Institute (NHLBI).

NCT00471250 is a study of Respiratory Tract Diseases and Bronchoscopy that is actively recruiting participants, run by National Heart, Lung, and Blood Institute (NHLBI). The registered enrollment target is 550 participants, below the 2,205-participant average among 8 other Respiratory Tract Diseases trials with a reported enrollment target (75% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00471250, a study of Respiratory Tract Diseases and Bronchoscopy, is actively recruiting participants, sponsored by National Heart, Lung, and Blood Institute (NHLBI).

RECRUITING
Registry status
550 participants
Enrollment target
1
Study location

Study Summary

This study will collect fluid and tissue specimens from the lungs and nose of healthy people and people with a history of lung infections. The specimens will be examined for differences between the two groups that may be associated with susceptibility to certain infections. Healthy normal volunteers and people with a history of lung infections between 18 and 75 years of age who are followed at NIH may be eligible for this study. Participants undergo the following procedures: Medical history and physical examination. Blood and urine tests. Electrocardiogram (ECG) and chest x-ray. Treadmill exercise stress test (for people over 45 years old with a history of chest pain or ECG abnormalities). Bronchoscopy: The subject s nose and throat are numbed with lidocaine and a sedative is given for comfort. A thin flexible tube called a bronchoscope is advanced through the nose or mouth into the lung airways to examine the airways carefully. Fluid collection during the bronchoscopy using one of the following methods: * Bronchoalveolar lavage: Salt water is injected through the bronchoscope into the lung and immediately suctioned out, washing off cells lining the airways. * Bronchial brushings: A brush-tipped wire enclosed in a sheath is passed through the bronchoscope and a small area of the airway tissue is gently brushed. The brush is withdrawn with some tissue adhering to it. * Endobronchial biopsies: Small pinchers on a wire are passed through the bronchoscope and about 1 to 2 millimeters of tissue is removed. * Nasal scrape: A small device is used to scrape along the inside of the nose to collect some cells. * Sputum induction * Exhaled breath condensate to obtain specimens for in vitro investigations and comparisons of both the cellular and acellular components. * Nasal nitric oxide production * Nasal potential difference * Exhaled aerosol mask sample collection * Cough aerosol collection * Exhaled particle collection * Lung Clearance Index (LCI)

Primary Outcome

to obtain respiratory tract cells fluids, and bedside physiologic measurements from normal and diseased subjects to support current bench research studies or to be stored for future studies.

Study Locations (1)

Maryland

  • National Institutes of Health Clinical Center - Bethesda

Trial Details

FieldValue
Enrollment Target 550 participants
Start Date 2007-08-17

What NCT00471250 shows while recruiting

NCT00471250 is an observational study that tracks outcomes without assigning an intervention. The registered 550 participants enrollment target is mid-sized for trials with a published cap, below the 2,205-participant average among 8 other Respiratory Tract Diseases trials with a reported enrollment target (75% lower).

The record links to 3 conditions, with Respiratory Tract Diseases appearing as the primary indexed condition, and to 0 interventions.

NCT00471250 reports a single indexed study location in Maryland.

Frequently Asked Questions

What is clinical trial NCT00471250 about?

NCT00471250 is a clinical study titled "Collection of Lung Fluid and Tissue Samples for Research". This study will collect fluid and tissue specimens from the lungs and nose of healthy people and people with a history of lung infections. The specimens will be examined for differences between the two groups that may be associated with susceptibility to certain infections. Healthy normal volunteer...

What is the current status of trial NCT00471250?

This trial is currently recruiting. The enrollment target is 550 participants. The study started on 2007-08-17.

What conditions does trial NCT00471250 study?

This clinical trial studies the following conditions: Respiratory Tract Diseases, Bronchoscopy, Leukocyte Disorders.

Who is sponsoring clinical trial NCT00471250?

This trial is sponsored by National Heart, Lung, and Blood Institute (NHLBI), which has 501 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00471250 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Respiratory Tract Diseases

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00471250's enrollment target sits among peer trials

550 4th of 8 higher than 5 of 8 other Respiratory Tract Diseases trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Respiratory Tract Diseases trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01852448 · 550 participants

    Genetics of Insulin and Incretins in Cystic Fibrosis

  • NCT02995252 · 550 participants

    The HOPE Study: Characterizing Patients With Hepatitis B and C

  • NCT03474913 · 550 participants

    Upright MRI for Prostate Cancer Screening

  • NCT04761120 · 550 participants

    Annuloplasty Rings and Band Post-Market Clinical Follow-Up Study

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT00471250, the US trial registry maintained by the National Library of Medicine. NCT00471250 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.